White Matter Hyperintensities on T2-Weighted MRI Images among DNA-Verified Older Familial Hypercholesterolemia Patients

References

• Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. The metabolic and molecular bases of inherited diseaseEighth ed, CR Scriver, AL Beaudet, WS Sly, D Valle, B Childs, KW Kinzler. McGraw-Hill Book Co, New York 2001; 2863–913
   Google Scholar
• Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolemia: implications for clinical management. Atherosclerosis 1999;142:105–12.
   PubMed Web of Science ®Google Scholar
• Gerdes VEA, Kwa VIH, ten Cate H, Brandjes DPM, Büller HR, Stam J. Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis 2006; 186: 166–72
   PubMed Web of Science ®Google Scholar
• Kuller LH, Longstreth WT, Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ, Jr. Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004;35:1821–5.
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34: 1126–9
   PubMed Web of Science ®Google Scholar
• Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28: 652–9
   PubMed Web of Science ®Google Scholar
• Autti T, Raininko R, Vanhanen SL, Kallio M, Santavuori P. MRI of the normal brain from early childhood to middle age. I. Appearances on T2- and proton density-weighted images and occurrence of incidental high-signal foci. Neuroradiology 1994; 36: 644–8
   Google Scholar
• Salonen O, Autti T, Raininko R, Ylikoski A, Erkinjuntti T. MRI of the brain in neurologically healthy middle-aged and elderly individuals. Neuroradiology 1997; 39: 537–45
   Google Scholar
• Soljanlahti S, Autti T, Lauerma K, Raininko R, Keto P, Turtola H, et al. Familial hypercholesterolemia patients treated with statins at no increased risk for intracranial vascular lesions despite increased cholesterol burden and extracranial atherosclerosis. Stroke 2005; 36: 1572–4
   PubMedGoogle Scholar
• Soljanlahti S, Raininko R, Hyttinen L, Lauerma K, Keto P, Vuorio AF, et al. Statin-treated familial hypercholesterolemia patients with coronary heart disease and pronounced atherosclerosis do not have more brain lesions than healthy controls in later middle age. Acta Radiol 2007; 48: 894–9
   PubMed Web of Science ®Google Scholar
• Schmitz SA, O'Regan DP, Fitzpatrick J, Neuwirth C, Potter E, Tosi I, et al. White matter brain lesions in midlife familial hypercholesterolemic patients at 3-Tesla magnetic resonance imaging. Acta Radiol 2008; 49: 184–9
   PubMed Web of Science ®Google Scholar
• Vuorio AF, Turtola H, Piilahti K-M, Repo P, Kanninen T, Kontula K. Familial hypercholesterolemia in the Finnish North Karelia. A molecular, clinical and genealogical study. Arterioscler Thromb Vasc Biol 1997; 17: 3127–38
   PubMed Web of Science ®Google Scholar
• Longstreth WT, Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al., Cardiovascular Health Study Collaborative Research Group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274–82.
   PubMed Web of Science ®Google Scholar
• de Leeuw F-E, de Groot JC, Achten E, Oudkerk M, Ramos LMP, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70: 9–14
   PubMed Web of Science ®Google Scholar
• Murray AD, Staff RT, Shenkin SD, Deary IJ, Starr JM, Whalley LJ. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005; 237: 251–7
   PubMed Web of Science ®Google Scholar
• Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997; 16: 149–62
   PubMed Web of Science ®Google Scholar
• Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007; 357: 1821–8
   PubMed Web of Science ®Google Scholar
• Giele JLP, Witkamp TD, Mali WPTM, van der Graaf Y, for the SMART Study Group. Silent brain infarcts in patients with manifest vascular disease. Stroke 2004;35:742–6.
   PubMed Web of Science ®Google Scholar
• Price TR, Manolio TA, Kronmal RA, Kittner SJ, Yue NC, Robbins J, et al., for the CHS Collaborative Research Group. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults: the Cardiovascular Health Study. Stroke 1997;28:1158–64.
   PubMed Web of Science ®Google Scholar
• Miida T, Takahashi A, Ikeuchi T. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects. Pharmacol Ther 2007; 113: 378–93
   Google Scholar
• Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Br Med J 2003; 326: 1423–9
   PubMed Web of Science ®Google Scholar
• Kaste M, Koivisto P. Risk of brain infarction in familial hypercholesterolemia. Stroke 1988; 19: 1097–100
   PubMedGoogle Scholar
• Vaughan CJ, Delanty N, Basson CT. Statin therapy and stroke prevention. Curr Opin Cardiol 2001; 16: 219–24
   Google Scholar